Trinseo Offers Polymers, Specialty Engineered Solutions for Drug Delivery Devices
- $TSE--Trinseo
(NYSE: TSE), the global materials solution provider and manufacturer of
plastics, latex binders and synthetic rubber, announced today that its
Consumer Essential Markets (CEM) business unit will now support medical
device and pharmaceutical manufacturers of Drug
Delivery Devices with specialty engineered polymer solutions.
Typical drug delivery devices, also known as combination devices that can use Trinseo materials include auto injectors, insulin pens, asthma inhalers, prefilled syringes and wearable devices. The Company’s specialty compounded solutions are ideal for a wide range of applications – acrylonitrile butadiene styrene (ABS) for housings, polycarbonate (PC) for windows and needle shield caps, and polystyrene (PS) for secondary packaging.
Trinseo materials are offered under the brands CALIBRE™ Polycarbonate Resins, CALIBRE™ MEGARAD™ Polycarbonate Resins, EMERGE™ Advanced Resins, STYRON™ Polystyrene Resins and MAGNUM™ ABS Resins. They provide advantages which are critical to the market such as:
- Appearance and color options
- High impact resistance and toughness
- High stiffness/modulus
- Low residual monomer and oligomer levels
- Radiation and Ethylene Oxide sterilization
- Biocompatiblity tested resins and colors
Trinseo materials have been developed to meet the needs of manufacturers and molders - and they can be customized to meet exacting specifications. Trinseo medical grades have been biocompatibility tested and certain products are listed on a U.S. FDA Master Access File or Drug Master File.
The Company’s focus on drug delivery devices expands its support in the Medical Devices space which has included Single- and Multiple-Use Devices and Equipment Housings. As healthcare professionals embrace self-administered care they need devices that not only are effective therapeutically but also offer their patients functionality, convenience, haptics and aesthetics. Polymers are a big part of the challenge and Trinseo, with a foundation in medical polymers, intends to offer the solution.
About Trinseo
Trinseo (NYSE:TSE) is a global materials solutions provider and manufacturer of plastics, latex binders, and synthetic rubber. We are focused on delivering innovative and sustainable solutions to help our customers create products that touch lives every day — products that are intrinsic to how we live our lives — across a wide range of end-markets, including automotive, consumer electronics, appliances, medical devices, lighting, electrical, carpet, paper and board, building and construction, and tires. Trinseo had approximately $3.7 billion in net sales in 2016, with 15 manufacturing sites around the world, and nearly 2,200 employees. For more information visit www.trinseo.com.
Forward Looking Statements
This press release may contain “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. Forward-looking statements in this press release may include, without limitation, forecasts of growth, revenues, business activity, acquisitions, financings and other matters that involve known and unknown risks, uncertainties and other factors that may cause results, levels of activity, performance or achievements to differ materially from results expressed or implied by this press release. As a result of the foregoing considerations, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
ContactsTrinseo
Paula Biskup, +1-248-802-2783
[email protected]
&source=" target="_blank" />
Company supports growth in self-administered healthcare
BERWYN, Pa.–(BUSINESS WIRE)–$TSE—Trinseo
(NYSE: TSE), the global materials solution provider and manufacturer of
plastics, latex binders and synthetic rubber, announced today that its
Consumer Essential Markets (CEM) business unit will now support medical
device and pharmaceutical manufacturers of Drug
Delivery Devices with specialty engineered polymer solutions.
Typical drug delivery devices, also known as combination devices that
can use Trinseo materials include auto injectors, insulin pens, asthma
inhalers, prefilled syringes and wearable devices. The Company’s
specialty compounded solutions are ideal for a wide range of
applications – acrylonitrile butadiene styrene (ABS) for housings,
polycarbonate (PC) for windows and needle shield caps, and polystyrene
(PS) for secondary packaging.
Trinseo materials are offered under the brands CALIBRE™
Polycarbonate Resins, CALIBRE™
MEGARAD™ Polycarbonate Resins, EMERGE™
Advanced Resins, STYRON™
Polystyrene Resins and MAGNUM™
ABS Resins. They provide advantages which are critical to the market
such as:
- Appearance and color options
- High impact resistance and toughness
- High stiffness/modulus
- Low residual monomer and oligomer levels
- Radiation and Ethylene Oxide sterilization
- Biocompatiblity tested resins and colors
Trinseo materials have been developed to meet the needs of manufacturers
and molders – and they can be customized to meet exacting
specifications. Trinseo medical grades have been biocompatibility tested
and certain products are listed on a U.S. FDA Master Access File or Drug
Master File.
The Company’s focus on drug delivery devices expands its support in the
Medical Devices space which has included Single-
and Multiple-Use Devices and Equipment
Housings. As healthcare professionals embrace self-administered care
they need devices that not only are effective therapeutically but also
offer their patients functionality, convenience, haptics and aesthetics.
Polymers are a big part of the challenge and Trinseo, with a foundation
in medical polymers, intends to offer the solution.
About Trinseo
Trinseo (NYSE:TSE) is a global materials solutions provider and
manufacturer of plastics, latex binders, and synthetic rubber. We are
focused on delivering innovative and sustainable solutions to help our
customers create products that touch lives every day — products that are
intrinsic to how we live our lives — across a wide range of end-markets,
including automotive, consumer electronics, appliances, medical devices,
lighting, electrical, carpet, paper and board, building and
construction, and tires. Trinseo had approximately $3.7 billion in net
sales in 2016, with 15 manufacturing sites around the world, and nearly
2,200 employees. For more information visit www.trinseo.com.
Forward Looking Statements
This press release may contain “forward-looking statements” within
the meaning of the safe harbor provisions of the United States Private
Securities Litigation Reform Act of 1995. Words such as “expect,”
“estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,”
“plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,”
“potential,” “continue,” and similar expressions are intended to
identify such forward-looking statements. Forward-looking statements in
this press release may include, without limitation, forecasts of growth,
revenues, business activity, acquisitions, financings and other matters
that involve known and unknown risks, uncertainties and other factors
that may cause results, levels of activity, performance or achievements
to differ materially from results expressed or implied by this press
release. As a result of the foregoing considerations, you are cautioned
not to place undue reliance on these forward-looking statements, which
speak only as of the date of this press release. The Company undertakes
no obligation to publicly update or revise any forward-looking
statements, whether as a result of new information, future events or
otherwise.
Contacts
Trinseo
Paula Biskup, +1-248-802-2783
[email protected]
